Sunday, September 17, 2017

PKD Life: Kidney Gift Voucher, Radio Voice for PKD, Walk for PKD, Delaware, Across Canada, PKD Research: Epidemiology Report

Living with PKD

From Scientific American, By Fran Kritz

This Gift Voucher Might Just Get You a Kidney

About 30 hospitals participate in this national program

Seven-year-old Quinn Gerlach got a gift certificate from his grandpa a few years back—not for a toy, a book or a game. It was for a kidney.

Gerlach was born with a single kidney, instead of the usual two, and it doesn’t fully function. So, one day, he may need a transplant.

Quinn’s grandfather, retired Tulare County Superior Court judge Howard Broadman, 68, of Visalia, Calif., learned he has the right blood and tissue types to be a donor for Quinn. But Broadman feared he might die or be too sick to donate a kidney when it was needed.

The former judge tried to think creatively, as he had on the bench—where he was known for unconventional and sometimes highly controversial sentencing.

He came up with what might be called the delayed kidney swap: He gave his kidney three years ago to Kathy DeGrandis, a retired airport manager in her 50s, at Ronald Reagan UCLA Medical Center. In exchange, Quinn was given a voucher that gives him priority to receive a live donor kidney, provided a match can be found when a transplant is necessary.

The idea caught on. Now about 30 hospitals around the country participate in this voucher program, administered by the National Kidney Registry. At least 21 kidneys have been donated by people in the U.S. in exchange for vouchers, according to the registry.

“If Quinn had needed the kidney right away, I was going to donate my kidney,” said Broadman. “But once he didn’t need it right away, I thought, why not pay it forward and maybe karma would come about.”

STILL WAITING, BUT WORRYING LESS

More than 93,000 people await kidney transplants in the United States, and each year 4,500 people die before they can get one.

Most patients seeking a transplant join the long waiting list for kidneys from deceased donors. Some are able find a living person willing to donate a kidney. Live donor kidneys are most desirable—the organs last up to 12 years longer—but are less available.

Another limiting factor for a successful transplant is that the donor kidney must be a good “match,” carrying a compatible complement of genetic markers with the patient in need.

To address that problem, doctors more than a dozen years ago devised a process known as donation “chains.” If a friend or relative wanted to donate to a patient but was not a good match, he could donate to another kidney patient in the same predicament, with a willing but incompatible donor.

Each transplant patient in the chain must have a donor who matches someone who currently needs a kidney in the U.S. and is willing to donate to that stranger. Hospitals and transplant centers have matched up to 35 pairs in such chains.

Broadman, the Visalia grandfather, took that idea further, proposing that donors be able to give their organs in advance—essentially to save a person today so that a relative might be saved down the road. {Read more]



From Minneapolis Star Tribune, By KEVYN BURGER


Michele Jansen’s voice is her instrument.

For decades, the Minneapolis resident has used her well-modulated and expressive voice to support herself and her family.

As general manager at Minneapolis jazz and traffic radio station KBEM (88.5 FM), Jansen, 59, regularly hosts on-air shifts. She’s also been a freelance audio artist, voicing commercials and narrating scores of projects, from technical reports for 3M to the audio tour at the American Swedish Institute in Minneapolis.

Now she’s raising her voice in an effort to save her life and help others like her.

“I have the most common life-threatening genetic disease that no one knows about,” she said.

Jansen lives with polycystic kidney disease (PKD), which causes cysts to grow in the kidneys and leads to kidney failure. For the past three years, she has been on dialysis and is at the top of the list for a kidney transplant.

“A kidney should be the size of a fist,” she said. “Mine are like footballs.”

On Sept. 16, Jansen will host the Twin Cities Walk for PKD at the Normandale Bandshell in Bloomington. The annual event raises funds for research and advocacy for those with the disease.

“The first year I attended the walk, I was feeling fine and, honestly, I didn’t want to be around other people with this chronic illness who are at a more advanced stage,” she said. “You see your future and it isn’t pretty.”

Since then, she has volunteered to organize the event and be its voice. “We need research to find more ways to treat PKD or find a cure,” she said.

Being part of the walk has been helpful for Jansen, who said she “called in a few favors” for this year’s event. “It’s a fun day, and we can promise some fantastic live jazz from local musicians.”

Even before Jansen was diagnosed with PKD at age 24, the disease had shaped her. Her mother died of complications of PKD when she was 46 and Jansen was just 6.

“In one of the few pictures I have of us together, we’re both sleeping. My memories of my mother are fuzzy, but I remember her always being tired,” Jansen recalled.

Parents with PKD have a 50 percent chance of passing on the disease. One of Jansen’s four siblings also has it; her middle brother had a kidney transplant, and both of his children have PKD.

“We say we lost the lottery,” she said. “It’s a weird disease with a range of symptoms and prognoses. My brother’s kidneys stopped functioning in his mid-40s; mine were OK until my mid-50s.” [Read more]




Walk for PKD

From Newark Post

Delaware Walk for PKD:
Saturday, 10 a.m. at Glasgow Park, 2275 Pulaski Highway. Two walks - a 1-mile course and a 2-mile course - will raise money for polycystic kidney disease research. Register at walkforpkd.org/delaware.



From Owen Sound Sun Times, Canada, By Rob Gowan

Kidney Walk raises funds, awareness


Sean Stobbe isn't sure when he will find out when he will receive a kidney transplant, but he expects mixed emotions when that match is found.

"It is going to be a combination of fear and excitement to finally get it all over with, but it is pretty major surgery," Stobbe, 28, said Saturday at Harrison Park where he was taking part in the annual Kidney Walk. "I have had some complications with my dialysis so I had to get some day surgery done earlier this year to correct it and that was nerve-wracking enough."

When Stobbe, who has polycystic kidney disease, will receive that transplant there is no way of knowing, so he is waiting patiently.

"It is whenever a suitable match becomes available," said Stobbe. "The average wait is a year-and-a-half and I am only at five months right now, so I might be waiting another year to hit the average."
Stobbe said living with kidney disease is a hassle for him. He has to undergo dialysis four times a day and each time it lasts 30-45 minutes.
"It disrupts my work days and everything," said Stobbe, a supervisor at Owen Sound Ledgerock. "All these exchanges of dialysis fluid."

For Stobbe, being diagnosed with the disease didn't come as a surprise. The disease is genetic and his grandmother had it, as did his uncle and his father Tom. 

"I actually went to see the doctor with some foot pain, thinking it was plantar fasciitis and my blood pressure was astronomically high and I was sent for bloodwork," said Stobbe. "I came back with a pretty conclusive kidney disease result."

Stobbe said he feels pretty good since he started dialysis compared to the way he felt before.
"I have noticeably more energy than I did at the end of the winter before I started dialysis," he said. "From what I have heard, dialysis feels like a cure, and then when you get a transplant it feels that much better again."

But Stobbe remains optimistic one day he will receive that transplant and live a healthy and almost normal life. All the members of his family who had the disease had successful transplants, including his father more than 15 years ago.
"You just have to deal with a lot of the medications and you have to visit clinics to make sure everything is working properly," said Stobbe. "Aside from that you live a pretty normal life with a transplant."

The Owen Sound walk was one of more than 100 being held across Canada to raise awareness and funds to support Kidney Foundation programs and kidney research.
One in 10 Canadians is living with kidney disease, which usually progresses silently, often destroying most of the kidney function before causing any symptoms. The kidney is the organ that filters waste products from the blood in order to make urine.

"Kidney disease doesn't have the same public profile as some other ailments, even though it effects one in 10 Canadians," said Stobbe, who is the local Kidney Walk ambassador. "It is quite common."
Stobbe was taking part in his second walk on Saturday since he had been diagnosed with polycystic kidney disease in late 2015 and he feels it is important for him to be a part of that.

"It is nice to see more people coming out, and it would be nice to see more people still and get more donations," said Stobbe. "We are working on it and it is becoming a bigger event. I would like to help make it even bigger."



PKD Research

From ENA

Polycystic Kidney Disease Epidemiology Insights 2017 to 2025

Polycystic Kidney Disease- Competitive Landscape, Pipeline and Market Analysis, 2017, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of action. Key objective of the report is to establish the understanding for all the marketed and pipeline drugs that fall under Polycystic Kidney Disease. This report provides information on the therapeutic development based on Polycystic Kidney Disease mechanism of action dealing with around 120+ active pipeline drugs. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Report contains the development and sale activities for marketed drugs. Delve Insight’s Report also assesses the Polycystic Kidney Disease therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration. The report also covers the information for 28+ active companies involved in the therapeutic development of the products

Request for a Demo Report at: https://www.diligentmarket.com/request-sample-page.php?gturl=15409

Scope of this report: The report provides competitive pipeline landscape of Polycystic Kidney Disease. The report provides the marketed drugs information including its sales, development activities and details of patent expiry. The report provides the insight of current and future market for Polycystic Kidney Disease. The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information. Coverage of the Polycystic Kidney Disease pipeline on the basis of target, MOA, route of administration, technology involved and molecule type. The report reviews key players involved in the therapeutics development for Polycystic Kidney Disease and also provide company profiling. The report also gives the information of dormant pipeline projects. Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages and Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type. [Read more]

Sunday, September 3, 2017

PKD Research: Targeting New Disease Pathways, Explaining Kidney Disease Symptoms and Tests

PKD Research

From Oxford University Press

Targeting new cellular disease pathways in autosomal dominant polycystic kidney disease


Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited cause of end-stage renal failure. Understanding the molecular and cellular pathogenesis of ADPKD could help to identify new targets for treatment. The classic cellular cystic phenotype includes changes in proliferation, apoptosis, fluid secretion, extracellular matrix and cilia function. However, recent research, suggests that the cellular cystic phenotype could be broader and that changes, such as altered metabolism, autophagy, inflammation, oxidative stress and epigenetic modification, could play important roles in the processes of cyst initiation, cyst growth or disease progression. Here we review these newer cellular pathways, describe evidence for their possible links to cystic pathogenesis or different stages of disease and discuss the options for developing novel treatments.




Living with PKD

From Middle East North Africa Financial News (MENAFN)

Explainer: what is chronic kidney disease and why are one in three at risk of this silent killer?

A 42-year-old man – a father, a husband, a son – has come to the emergency department with a splitting headache. It's been there for months, slowly getting worse. Today it's unbearable.

He has no significant past medical history to explain the headaches and takes no regular medications. But he smokes and his is sky high – 210/100 mmHg (good blood pressure is 120/80 mmHg).

A series of investigations including blood and urine tests reveal significant kidney damage – stage four chronic kidney disease. Stage five kidney disease would mean he needs dialysis or a kidney transplant. This is serious.

Kidney disease is silent. Currently have evidence of chronic kidney disease, with many unaware of it. It's not of kidney function is lost that symptoms become apparent.

While symptoms like nausea, loss of appetite, lethargy and poor concentration are hallmarks of kidney failure, they are quite non-specific. Most people will have had these symptoms at some stage.

Fluid retention - swollen ankles and puffiness around the eyes - can be a marker of kidney disease. That's because the kidneys are key to regulating fluid in the body and a diseased kidney cannot do that as efficiently.

Using a blood and urine test. The blood test (serum electrolyes) gives you a 'percent of kidney function'. And the urine test (urinanalysis) tests for blood and protein in the urine, markers of damage and inflammation.What happens when your kidneys don't work well?

Kidneys are responsible for removing fluid and waste from your body that accumulate each day.

But when kidney function declines, fluid accumulates in the body. So, your legs can swell, and fluid can build up in the lungs, making it difficult to breathe.

Impaired kidneys also mean you cannot efficiently get rid of waste products, so these accumulate too. Such toxins in the body account for much of the symptoms of fatigue, nausea and loss of appetite.

Loss of kidney function and the build-up of fluid may lead to high blood pressure, which in turn may further speed up decline in kidney function. High pressures pulsating through the kidney damages their delicate filters and cause scar tissue to form.Loss of kidney function can lead to high blood pressure, which in turn can further speed up kidney disease.

People with chronic kidney disease are more likely to die from a heart attack or stroke. So, many people will die from heart disease before reaching end-stage kidney disease, the final stage of chronic kidney disease in which the kidneys no longer function well enough to meet your body's daily needs.

When healthy, kidneys secrete the hormone erythropoietin (or EPO), which stimulates red blood cells to form. But as kidney function declines, production of this hormone is impaired and anaemia (a low red blood cell count), follows. So, patients need to be injected with EPO to restore their red blood cell count.

The kidneys are also pivotal in maintaining calcium and phosphate levels in the blood. As phosphate builds up, severe itchiness can develop; calcium levels drop and, without attention, this can lead to fragile bones.Who is at risk?

Kidney disease is related to and caused by a number of different factors and conditions. As many as have at least one risk factor for chronic kidney disease.

Indigenous Australians are at risk with this risk increasing the more remotely they live. People with a family history of kidney disease are particularly vulnerable to it. Diabetes, high blood pressure, smoking, obesity, high cholesterol, heart disease, stroke and being over 60 are additional risks.

The number of people with chronic (long-term) kidney disease is forecast to increase by , largely due to diabetes and obesity becoming more common.

Anyone who has had an episode of acute kidney injury is also at risk of later developing chronic kidney disease. {Read more]